Stephen Chambers is a General Partner at SOSV and Managing Director of IndieBio NY. He has experience as a scientist at Vertex Pharmaceuticals and as CEO of SynbiCITE.
At firms with a similar stage, sector and check size.
One email when Stephen's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckStephen Chambers is a General Partner at SOSV and Managing Director of IndieBio NY. He has experience as a scientist at Vertex Pharmaceuticals and as CEO of SynbiCITE.
Stephen Chambers invests through SOSV SF & NY (Fka IndieBio), which writes checks of $500K to $1M at pre-seed.
A warm intro from a founder SOSV SF & NY (Fka IndieBio) backed works best.
founding scientist at Vertex Pharmaceuticals; Abpro Therapeutics; CEO at SynbiCITE; Bio-start; mentor at IndieBio; General Partner, SOSV & Managing Director at SOSV.
Last updated 2026-10-15. Is this you? Ask for a correction.